MGC BioPQQ
MGC BioPQQ, a subsidiary of the MGC Group, is a leading player in the biotechnology industry, headquartered in Japan. Established in 2015, the company has rapidly gained recognition for its innovative approach to health and wellness, particularly in the development of bioactive compounds. Specialising in the production of Pyrroloquinoline Quinone (PQQ), MGC BioPQQ offers unique products that support cellular energy and overall vitality. Their commitment to quality and scientific research has positioned them as a trusted name in the market, catering to both domestic and international clients. With a focus on sustainability and cutting-edge technology, MGC BioPQQ continues to make significant strides in the health supplement sector, contributing to advancements in nutritional science and enhancing consumer well-being.
DitchCarbon Score
How does MGC BioPQQ's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MGC BioPQQ's score of 21 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MGC BioPQQ's reported carbon emissions
In 2023, MGC BioPQQ reported total greenhouse gas emissions of approximately 9,265,000,000 kg CO2e, comprising Scope 1 emissions of about 715,000,000 kg CO2e, Scope 2 emissions of approximately 682,000,000 kg CO2e, and Scope 3 emissions totalling around 9,265,000,000 kg CO2e. Over the years, MGC BioPQQ has shown a trend of fluctuating emissions, with a notable decrease from about 1,431,000,000 kg CO2e in 2014 to 1,396,000,000 kg CO2e in 2023. However, specific reduction targets or initiatives have not been disclosed, indicating a potential area for improvement in their climate commitments. The company has not established any formal reduction targets under the Science Based Targets initiative (SBTi) or other climate pledges, which may limit their accountability in addressing climate change. As MGC BioPQQ continues to operate in a climate-conscious industry, enhancing their emissions reduction strategies could significantly contribute to global sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 603,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 247,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 7,966,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MGC BioPQQ is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
